Louis Trevisan, MD.
Clinical professor of psychiatry, Creighton University School of Medicine, Omaha, NE; associate professor of psychiatry, adjunct, Yale School of Medicine, New Haven, CT.
Dr. Trevisan has no financial relationships with companies related to this material.
Margo C. Funk, MD, MA, FACLP.
Director of Cardiovascular Psychiatry, Vice Chair for Education, Residency Program Director, Department of Psychiatry, Brigham and Women’s Hospital, Boston, MA.
Dr. Funk has disclosed that in 2021, she received fees as a consultant for Acadia Pharmaceuticals. Dr. Aiken has reviewed this educational activity and has determined that there is no commercial bias as a result of this financial relationship.
“About half of older adults with depression have evidence of a vascular contribution [to the mood disorder] on MRI, and the rate goes up with age.”
Margo C. Funk, MD, MA, FACLP.
Director of Cardiovascular Psychiatry, Vice Chair for Education, Residency Program Director, Department of Psychiatry, Brigham and Women’s Hospital, Boston, MA.
Dr. Funk has disclosed that in 2021, she received fees as a consultant for Acadia Pharmaceuticals. Dr. Aiken has reviewed this educational activity and has determined that there is no commercial bias as a result of this financial relationship.
Kristin Cadenhead, MD.
Professor of psychiatry. Director, Cognitive Assessment and Risk Evaluation (CARE) Early Psychosis Treatment and Research Program, University of California, San Diego.
Dr. Cadenhead has no financial relationships with companies related to this material.
Paul Lipkin, MD.
Neurodevelopmental and developmental behavioral pediatrician. Director, Medical Outpatient Services, Kennedy Krieger Institute, Baltimore, MD.
Dr. Lipkin has served as an advisor for EarliTec and Sarepta Diagnostics. Relevant financial relationships listed for the author have been mitigated.
Lewei (Allison) Lin, MD, MS. Associate professor, Department of Psychiatry, University of Michigan Medical School; research scientist, Center for Clinical Management Research, VA Ann Arbor Healthcare System. Ann Arbor, MA.
Dr. Lin has served as a consultant for the National Committee for Quality Assurance via a grant from Alkermes. Relevant financial relationships listed for the author have been mitigated.
Karen Moeller, PharmD. Clinical professor, Department of Pharmacy Practice, University of Kansas School of Pharmacy. Lawrence, KS. Board-certified psychiatric pharmacist, inpatient psychiatry unit, University of Kansas Health Systems. Kansas City, KS.
Dr. Moeller has no financial relationships with companies related to this material.
Bryan K. Tolliver, MD, PhD
Associate professor, Addiction Sciences Division, Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina. Charleston, SC.
Dr. Tolliver has no financial relationships with companies related to this material.
“When tailoring medication choice, a careful history can guide you. If I’m treating a patient who drinks excessively at night to sleep or who struggles with insomnia when they try to stop drinking, I’ll start with a sedating antidepressant like mirtazapine. That’s not an evidence-based decision, it’s a clinical decision that I think can be helpful.”
David Beckmann, MD, MPH.
Assistant professor of psychiatry and human behavior, Sidney Kimmel Medical College, Thomas Jefferson University. Philadelphia, PA.
Dr. Beckmann has no financial relationships with companies related to this material.
Scott Mendelson, MD, PhD.
Recently retired after 25 years of practicing inpatient and outpatient psychiatry in community and VA hospitals. He is the author of several psychiatric textbooks including Herbal Treatment of Major Depression (CRC Press, 2019) and Herbal Treatment of Anxiety (CRC Press, 2022).
Dr. Mendelson has no financial relationships with companies related to this material.
_-The-Breakthrough-Antipsychotic-That-Could-Change-Everything.webp?t=1729528747 "KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg")
RSS
